Christoph Antz & VERAXA Biotech AG
5 shared events · Importance 4 · Last updated Jul 29, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Christoph Antz is the Chief Executive Officer and Co-Founder of VERAXA Biotech AG, leading the company's strategic direction and operations in developing novel cancer therapies.
Business
Christoph Antz: As CEO and Co-Founder of VERAXA, Christoph Antz announced the collaboration and expressed optimism about AI integration in drug development.
VERAXA Biotech AG: VERAXA is the primary beneficiary of the collaboration, gaining AI capabilities to enhance its BiTAC pipeline and potentially improve drug development success rates.
Jul 13, 2026 · 7 articles
Business
Christoph Antz: CEO Christoph Antz is quoted providing strategic direction and confidence in the BiTAC platform.
VERAXA Biotech AG: VERAXA is the subject of the update, detailing its pipeline progress and strategic shift toward BiTAC platform, which is expected to drive future value.
Jul 06, 2026 · 7 articles
Business
Christoph Antz: Christoph Antz, CEO and Co-Founder, commented on the patent developments, emphasizing the importance of IP strategy for the company.
VERAXA Biotech AG: VERAXA Biotech AG is the subject of the event; the patent update reinforces its IP protection for core platforms, supporting its long-term strategy in oncology therapeutics.
Jul 29, 2026 · 6 articles
Business
Christoph Antz: As CEO and Co-Founder, Antz is listed as a contact but not directly involved in the EGM proceedings.
VERAXA Biotech AG: VERAXA is the company holding the EGM; the approved resolutions enhance its corporate flexibility for future growth.
Jul 24, 2026 · 6 articles
Regulatory
Christoph Antz: Christoph Antz is CEO of VERAXA, but is not directly quoted or involved in this specific announcement.
VERAXA Biotech AG: VERAXA received supportive regulatory feedback for its lead BiTAC-TCE program, de-risking development and potentially enhancing its pipeline value.
Jul 20, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Christoph Antz and VERAXA Biotech AG interact across events, view sentiment trends, and discover connected entities.
Open Dashboard